Medtronic PLC vs ProShares UltraPro QQQ ETF — how do they compare? Medtronic PLC trades at $82 (market cap $105.41B), while ProShares UltraPro QQQ ETF trades at $69.74. The key difference: Medtronic PLC pays a 3.5% dividend while ProShares UltraPro QQQ ETF pays none, and ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | TQQQ | |
|---|---|---|
Market Cap | $105.41B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $87.22 |
52-Week Low | $73.75 | $37.89 |
Enterprise Value | $124.15B | — |
Dividend Yield | 3.5% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
TQQQ trades at $67.65, up 0.18% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF's structure amplifies daily Nasdaq-100 returns, yet financial ratios are unavailable as it's a leveraged fund tracking an index. Recent news highlights volatility risks, with articles warning of amplified losses during market downturns despite historical gains in bull markets.
Outlook remains cautious due to leverage decay and bearish technicals; opportunities exist for tactical traders during rebounds, but risks include heightened volatility and structural costs. Long-term holders face potential erosion from daily rebalancing, especially in sideways or declining markets.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →